|
Streptococcus agalactiae is the leading cause of neonatal
infections. Approximately 15-35% of healthy adult women are intermittently
colonized by GBS leading to invasive infections during pregnancy
and death or long-term disability in infants.
- The CDC recommends universal screening for your pregnant
patients between weeks 35 and 37 of gestation1
- 94% sensitivity by PCR vs. 54% by culture2,3
- Rapid 1 day turnaround with daily setups
For more information, you may refer to the documents on the right
or contact Client Services at 800-421-4449.
References
- Schrag S, et al. Prevention of perinatal group B streptococcal
disease. Revised guidelines from CDC. MMWR Recomm Rep 2002;51(RR-11):1-22
- Davies HD, et al. Multicenter study of a rapid molecular-based
assay for the diagnosis of Group B Streptococcus colonization
in pregnant women. Clin Infect Dis 2004;39:1129-35.
- IDI-Strep B(tm) Package Insert, Infectio Diagnostic Inc.,
2003.
Also see www.thejessecause.org
for patient information on GBS. |
